Current Problems in Surgery
Volume 47, Issue 4 , Pages 261-376 , April 2010

Care of the Pediatric Cardiac Surgery Patient—Part 2

  • Avihu Z. Gazit, MD

      Affiliations

    • Assistant Professor of Pediatric Critical Care Medicine and Cardiology, St. Louis Children's Hospital, Washington University School of Medicine, St. Louis, Missouri
    • ,
  • Charles B. Huddleston, MD

      Affiliations

    • Professor of Surgery, Director of Pediatric Cardiothoracic Surgery, St. Louis Children's Hospital, Washington University School of Medicine, St. Louis, Missouri
    • ,
  • Paul A. Checchia, MD

      Affiliations

    • Assistant Professor of Pediatric Critical Care Medicine and Cardiology, St. Louis Children's Hospital, Washington University School of Medicine, St. Louis, Missouri
    • ,
  • James Fehr, MD

      Affiliations

    • Associate Professor of Anesthesiology and Pediatrics, St. Louis Children's Hospital, Washington University School of Medicine, St. Louis, Missouri
    • ,
  • A. Thomas Pezzella, MD

      Affiliations

    • Retired Associate Professor of Cardiothoracic Surgery, University of Massachusetts Medical School, Worcester, Massachusetts

References 

  1. Curzon CL, Milford-Beland S, Li JS, et al. Cardiac surgery in infants with low birth weight is associated with increased mortality: analysis of the Society of Thoracic Surgeons congenital heart database. J Thorac Cardiovasc Surg. 2008;135:546–551
  2. Miyamoto T, Sinzobahamvya N, Photiadis J, et al. Survival after surgery with cardiopulmonary bypass in low weight patients. Asian Cardiovasc Thorac Ann. 2008;16:115–119
  3. Sachdeva R, Pedretti J. In: NACHRI Annual Meetings. Boston, MA 32006, and San Antonio, TX. 2007;
  4. Pollack MM, Patel KM, Ruttimann UE. PRISM III: an updated pediatric risk of mortality score. Crit Care Med. 1996;24:743
  5. Fiser DH. Assessing the outcome of pediatric intensive care. J Pediatr. 1992;121:68
  6. Silka MJ, Kron J, Halperin BD, et al. Mechanisms of AV node reentrant tachycardia in young patients with and without dual AV node physiology. Pacing Clin Electrophysiol. 1994;17(11 Pt. 2):2129–2133
  7. Leteurtre S, Martinot A, Duhamel A, et al. Validation of the Paediatric Logistic Organ Dysfunction (PELOD) score: prospective, observational, multicentre study. Lancet. 2003;362:192–197
  8. Perez JM, Lim E, Calvano SE, et al. Systemic response to injury and metabolic support. In:  Brunicardi FC,  Andersen DK,  Billiar TR, et al. editor. Schwartz’s Manual of Surgery. 8th edition. New York: McGraw-Hill; 2006;p. 3–31
  9. Epstein J, Breslow MJ. The stress response of critical illness [review]. Crit Care Clin. 1999;15:17–33
  10. Rassias AJ, Procopio A. Stress response and optimization of perioperative care. Dis Mon. 2003;49:517–554
  11. Jaksic T, Shew SB. Metabolic responses to illness and operation. In:  Ziegler MM,  Azizkhan RG,  Weber TR editor. Operative Pediatric Surgery. New York: McGraw-Hill Professional; 2003;p. 61–69
  12. Laussen PC. Pediatric cardiac intensive care. In:  Jonas RA editors. Comprehensive Surgical Management of Congenital Heart Disease. London: Arnold Pub; 2004;p. 65–115
  13. Brotman DJ, Golden SH, Wittstein IS. The cardiovascular toll of stress. Lancet. 2007;370:1089–1100
  14. Catchpole KR, de Leval MR, McEwan A, et al. Patient handover from surgery to intensive care: using formula 1 pit-stop and aviation models to improve safety and quality. Paediatr Anaesth. 2007;17:470–478
  15. Aneja R, Heard AM, Fletcher JE, et al. Sedation monitoring of children by the bispectral index in the pediatric intensive care unit. Pediatr Crit Care Med. 2003;4:60–64
  16. Ramsay MA, Savege TM, Simpson BR, et al. Controlled sedation with alphaxalone-alphadolone. BMJ. 1974;2:656–659
  17. Lamas A, López-Herce J, Sancho L, et al. Assessing sedation in critically ill children by bispectral index, auditory-evoked potentials and clinical scales. Intensive Care Med. 2008;34:2092–2099
  18. Ambuel B, Hamlett KW, Marx CM, et al. Assessing distress in pediatric intensive care environments: the COMFORT scale. J Pediatr Psychol. 1992;17:95–109
  19. Pinsky MR. Hemodynamic evaluation and monitoring in the ICU. Chest. 2007;132:2020–2029
  20. Zollner C, Haller M, Weis M, et al. Beat-to-beat measurement of cardiac output by intravascular pulse contour analysis: a prospective criterion standard study in patients after cardiac surgery. J Cardiothorac Vasc Anesth. 2000;14:125–129
  21. Sakka SG, Reinhart K, Meier-Hellmann A. Comparison of pulmonary artery and arterial thermodilution cardiac output in critically ill patients. Intensive Care Med. 1999;25:843–846
  22. Küntscher MV, Blome-Eberwein S, Pelzer M, et al. Transcardiopulmonary vs pulmonary arterial thermodilution methods for hemodynamic monitoring of burned patients. J Burn Care Rehabil. 2002;23:21–26
  23. Holm C, Melcer B, Hörbrand F, et al. Arterial thermodilution: an alternative to pulmonary artery catheter for cardiac output assessment in burn patients. Burns. 2001;27:161–166
  24. Friedman Z, Berkenstadt H, Margalit N, et al. Cardiac output assessed by arterial thermodilution during exsanguination and fluid resuscitation: experimental validation against a reference technique. Eur J Anaesthesiol. 2002;19:337–340
  25. Della Rocca G, Costa MG, Pompei L, et al. Continuous and intermittent cardiac output measurement: pulmonary artery catheter versus aortic transpulmonary technique. Br J Anaesth. 2002;88:350–356
  26. Della Rocca G, Costa MG, Coccia C, et al. Cardiac output monitoring: aortic transpulmonary thermodilution and pulse contour analysis agree with standard thermodilution methods in patients undergoing lung transplantation. Can J Anaesth. 2003;50:707–711
  27. Buhre W, Weyland A, Kazmaier S, et al. Comparison of cardiac output assessed by pulse-contour analysis and thermodilution in patients undergoing minimally invasive direct coronary artery bypass grafting. J Cardiothorac Vasc Anesth. 1999;13:437–440
  28. Tibby SM, Hatherill M, Marsh MJ, et al. Clinical validation of cardiac output measurements using femoral artery thermodilution with direct Fick in ventilated children and infants. Intensive Care Med. 1997;23:987–991
  29. Pauli C, Fakler U, Genz T, et al. Cardiac output determination in children: equivalence of the transpulmonary thermodilution method to the direct Fick principle. Intensive Care Med. 2002;28:947–952
  30. Isakow W, Schuster DP. Extravascular lung water measurements and hemodynamic monitoring in the critically ill: bedside alternatives to the pulmonary artery catheter. Am J Physiol Lung Cell Mol Physiol. 2006;29:L1118–L1131
  31. Rubens D, Schenkman KA, Martin LD. Noninvasive monitoring in children. In:  Fuhrman BP,  Zimmerman J editor. Pediatric Critical Care. Philadelphia: Mosby; 2006;
  32. Wahr JA, Tremper KK, Samra S, et al. Near-infrared spectroscopy: theory and applications [review]. J Cardiothorac Vasc Anesth. 1996;10:406–418
  33. Hoffman GM. Pro: near-infrared spectroscopy should be used for all cardiopulmonary bypass [review]. J Cardiothorac Vasc Anesth. 2006;20:606–612
  34. Watzman HM, Kurth CD, Montenegro LM, et al. Arterial and venous contributions to near-infrared cerebral oximetry. Anesthesiology. 2000;93:947–953
  35. Joly HR, Weil MH. Temperature of the great toe as an indication of the severity of shock. Circulation. 1969;39:131–138
  36. Wippermann CF, Schmid FX, Kampmann C, et al. Evaluation of gastric intramucosal pH during and after pediatric cardiac surgery. Eur J Cardiothorac Surg. 1997;12:190–194
  37. Duke T, Butt W, South M, et al. Early markers of major adverse events in children after cardiac operations. J Thorac Cardiovasc Surg. 1997;114:1042–1052
  38. Weil MH. Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (shock). Circulation. 1970;41:989–1001
  39. Seear MD, Scarfe JC, LeBlanc JG. Predicting major adverse events after cardiac surgery in children. Pediatr Crit Care Med. 2008;9:606–611
  40. Sudoh T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain. Nature. 1988;332:78–81
  41. Saito Y, Nakao K, Itoh H, et al. Brain natriuretic peptide is a novel cardiac hormone. Biochem Biophys Res Commun. 1989;158:360–368
  42. Kambayashi Y, Nakao K, Mukoyama M, et al. Isolation and sequence determination of human brain natriuretic peptide in human atrium. FEBS Lett. 1990;259:341–345
  43. Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans (Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide). J Clin Invest. 1991;87:1402–1412
  44. McGregor A, Richards M, Espiner E, et al. Brain natriuretic peptide administered to man: actions and metabolism. J Clin Endocrinol Metab. 1990;70:1103–1107
  45. Holmes SJ, Espiner EA, Richards AM, et al. Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. J Clin Endocrinol Metab. 1993;76:91–96
  46. La Villa G, Fronzaroli C, Lazzeri C, et al. Cardiovascular and renal effects of low dose brain natriuretic peptide infusion in man. J Clin Endocrinol Metab. 1994;78:1166–1171
  47. Jensen KT, Carstens J, Pedersen EB. Effect of BNP on renal hemodynamics, tubular function and vasoactive hormones in humans. Am J Physiol. 1998;274:F63–F72
  48. Thomas JA, Marks BH. Plasma norepinephrine in congestive heart failure. Am J Cardiol. 1978;41:233–243
  49. Levine TB, Francis GS, Goldsmith SR, et al. Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure. Am J Cardiol. 1982;49:1659–1666
  50. Leimbach WN, Wallin BG, Victor RG, et al. Direct evidence from intraneural recordings for increased central sympathetic outflow in patients with heart failure. Circulation. 1986;73:913–919
  51. Swedberg K, Eneroth P, Kjekshus J, et al. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality (CONSENSUS Trial Study Group). Circulation. 1990;82:1730–1736
  52. Yoshimura M, Yasue H, Morita E, et al. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation. 1991;84:1581–1588
  53. Cody RJ, Haas GJ, Binkley PF, et al. Plasma endothelin correlates with the extent of pulmonary hypertension in patients with chronic congestive heart failure. Circulation. 1992;85:504–509
  54. Dzau VJ, Colucci WS, Hollenberg NK, et al. Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation. 1981;63:645–651
  55. Kirklin JW, Archie JP. The cardiovascular subsystem in surgical patients. Surg Gynecol Obstet. 1974;139:17–23
  56. Kirklin JK, Kirklin JW, Tabbutt S. Management of the cardiovascular subsystem after cardiac surgery. Ann Thorac Surg. 1981;32:311–319
  57. Kentish JC, ter Keurs HE, Ricciardi L, et al. Comparison between the sarcomere length-force relations of intact and skinned trabeculae from rat right ventricle (Influence of calcium concentrations on these relations). Circ Res. 1986;58:755–768
  58. Babu A, Sonnenblick E, Gulati J. Molecular basis of the influence of muscle length on myocardial performance. Science. 1988;240:74–76
  59. Murray JM, Webber A. Competition between tropomyosin and cooperativity of the tropomyosin-actin filament. In:  Frinell AD,  Brazier MA editor. The Regulation of Muscle Contraction. Vol 261:New York: Academic Press; 1981;p. 261–275
  60. Leach JK, Priola DV, Grimes LA, et al. Shortening deactivation of cardiac muscle: physiological mechanisms and clinical implications. J Investig Med. 1999;47:369–377
  61. Baan J, van der Velde ET. Sensitivity of left ventricular end-systolic pressure-volume relation to the type of loading intervention in dogs. Circ Res. 1988;62:1247–1258
  62. Suga H, Kitabatake A, Sagawa K. End-systolic pressure determines stroke volume from fixed end-diastolic volume in the isolated canine left ventricle under a constant contractile state. Circ Res. 1979;44:238–249
  63. Baan J, De Bruin HG, van der Velde ET. Emax for the left ventricle in situ is influenced by muscle shortening. J Physiol. 1985;366:68P
  64. Burkhoff D, de Tombe PP, Hunter WC, et al. Contractile strength and mechanical efficiency of left ventricle are enhanced by physiological afterload. Am J Physiol. 1991;260(2 Pt. 2):H569–H578
  65. van der Velde ET, Burkhoff D, Steendijk P. Nonlinearity and load sensitivity of end-systolic pressure-volume relation of canine left ventricle in vivo. Circulation. 1991;83:315–327
  66. Teitel DF. Cardiac physiology: selected topics in normal hearts. In:  Chang AC,  Hanley FL,  Wernovsky G, et al. editor. Pediatric Cardiac Intensive Care. Philadelphia: Lippincott Williams & Wilkins; 1998;p. 25–36
  67. Hori M, Inoue M, Fukunami M, et al. An increase in afterload augments ventricular relaxation rate in isolated perfused canine hearts. Cardiovasc Res. 1985;19:649–654
  68. Hori M, Inoue M, Kitakaze M, et al. Loading sequence is a major determinant of afterload-dependent relaxation in intact canine heart. Am J Physiol. 1985;249(4 Pt. 2):H747–H754
  69. Raff GL, Glantz SA. Volume loading slows left ventricular isovolumic relaxation (Evidence of load-dependent relaxation in the intact dog heart). Circ Res. 1981;48:813–824
  70. Sagawa K. The ventricular pressure-volume diagram revisited. Circ Res. 1978;43:677–687
  71. Suga H. Left ventricular time varying pressure-volume ratio in systole as an index of myocardial inotropism. Jpn Heart J. 1971;12:153–160
  72. Sunagawa K, Sagawa K, Maughan WA. Ventricular interaction with the loading system. Ann Biomed Eng. 1984;12:163–189
  73. Little WC, Cheng CP. Left ventricular-arterial coupling in conscious dogs. Am J Physiol. 1991;261:H70–H76
  74. De Tombe PP, Jones S, Burkhoff D, et al. Ventricular stroke work and efficiency both remain nearly optimal despite altered vascular loading. Am J Physiol. 1993;264:H1817–H1824
  75. Van Hare GF, Hawkins JA, Schmidt KG, et al. The effects of increasing mean arterial pressure on left ventricular output in newborn lambs. Circ Res. 1990;67:78–83
  76. Cooper DS, Jacobs JP, Moore L, et al. Cardiac extracorporeal life support: state of the art in 2007. Cardiol Young. 2007;17:104–115
  77. Duncan BW. Extracorporeal membrane oxygenation for children with cardiac disease. In:  Duncan BW editors. Mechanical Support for Cardiac and Respiratory Failure in Pediatric Patients. New York: Marcel Dekker Inc; 2001;p. 1–20
  78. Extracorporeal Life Support Organization. ECLS registry report. Ann Arbor: Extracorporeal Life Support Organization; 2006;
  79. Morgan IS, Codispoti M, Sanger K, et al. Superiority of centrifugal pump over roller pump in paediatric cardiac surgery: prospective randomised trial. Eur J Cardiothorac Surg. 1998;13:526–532
  80. Karl TR, Horton SB. Centrifugal pump ventricular assist device in pediatric cardiac surgery. In:  Duncan BW editors. Mechanical Support for Cardiac and Respiratory Failure in Pediatric Patients. New York: Marcel Dekker Inc; 2001;p. 21–47
  81. Pavie A, Leger P. Physiology of univentricular versus biventricular support. Ann Thorac Surg. 1996;61:347–349discussion 357-8
  82. Ibrahim AE, Duncan BW, Blume ED, et al. Long-term follow-up of pediatric cardiac patients requiring mechanical circulatory support. Ann Thorac Surg. 2000;69:186–192
  83. Duncan BW, Hraska V, Jonas RA, et al. Mechanical circulatory support in children with cardiac disease. J Thorac Cardiovasc Surg. 1999;117:529–542
  84. del Nido PJ, Swan PR, Benson LN, et al. Successful use of intraaortic balloon pumping in a 2-kilogram infant. Ann Thorac Surg. 1998;46:574–576
  85. Scheidt S, Wilner G, Muyeller H, et al. Intra-aortic balloon counterpulsation in cardiogenic shock (Report of a cooperative clinical trial). N Engl J Med. 1973;288:979–984
  86. Pollock J, Charlton MC, Williams WG, et al. Inraaortic balloon pumping in children. Ann Thorac Surg. 1980;29:522–528
  87. Veasy LG, Blalock RC, Orth JL, et al. Intra-aortic balloon pumping in infants and children. Circulation. 1983;68:1095–1100
  88. Akomea-Agyin C, Kejriwal NK, Franks R, et al. Intraaortic balloon pumping in children. Ann Thorac Surg. 1999;67:1415–1420
  89. Reinhartz O, Keith FM, El-Banayosy A, et al. Multicenter experience with the thoratec ventricular assist device in children and adolescents. J Heart Lung Transplant. 2001;20:439–448
  90. Potapov EV, Stiller B, Hetzer R. Ventricular assist devices in children: current achievements and future perspectives. Pediatr Transplant. 2007;11:241–255
  91. McBride LR, Naunheim KS, Fiore AC, et al. Clinical experience with 111 thoratec ventricular assist devices. Ann Thorac Surg. 1999;67:1233–1238discussion 1238-9
  92. Helman DN, Addonizio LJ, Morales DL, et al. Implantable left ventricular assist devices can successfully bridge adolescent patients to transplant. J Heart Lung Transplant. 2000;19:121–126
  93. Fraser CD, Carberry KE, Owens WR, et al. Preliminary experience with the MicroMed DeBakey pediatric ventricular assist device. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2006;109–114
  94. Merkle F, Boettcher W, Stiller B, et al. Pulsatile mechanical cardiac assistance in pediatric patients with the Berlin heart ventricular assist device. J Extra Corpor Technol. 2003;35:115–120
  95. Hetzer R, Potapov EV, Stiller B, et al. Improvement in survival after mechanical circulatory support with pneumatic pulsatile ventricular assist devices in pediatric patients. Ann Thorac Surg. 2006;82:917–924discussion 924-5
  96. Gandhi SK, Huddleston CB, Balzer DT, et al. Biventricular assist devices as a bridge to heart transplantation in small children. Circulation. 2008;118(suppl 14):S89–S93
  97. Gregoratos G, Cheitlin MD, Conill A, et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices (A report of the American College of Cardiology/American Heart Association Task Force report on Practice guidelines). J Am Coll Cardiol. 1998;31:1175–1209
  98. Villain E, Bonner D, Trigo C, et al. Outcome of, and risk factors for, second degree atrioventricular block in children. Cardiol Young. 1996;6:315–319
  99. Michaëlsson M, Engel MA. Congenital complete heart block: an international study of the natural history [review]. Pediatr Cardiol. 1972;4:87–101
  100. Reed BR, Lee LA, Harmon C, et al. Autoantibodies to SS-A/Ro in infants with congenital heart block. J Pediatr. 1983;103:889–891
  101. Olah KS, Gee H. Antibody mediated complete congenital heart block in the fetus [review]. Pacing Clin Electrophysiol. 1993;16:1872–1879
  102. Epstein AE, DiMarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;51:e1–e62
  103. Weindling SN, Saul JP, Gamble WJ, et al. Duration of complete atrioventricular block after congenital heart disease surgery. Am J Cardiol. 1998;82:525–527
  104. Squarcia U, Merideth J, McGoon DC, et al. Prognosis of transient atrioventricular disturbances complicating open heart surgery for congenital heart defects. Am J Cardiol. 1971;28:648–652
  105. Murphy DA, Tynan M, Graham GR, et al. Prognosis of complete atrioventricular dissociation in children after open-heart-surgery. Lancet. 1970;1:750–752
  106. Daicoff GR, Aslami A, Tobias JA, et al. Management of post-operative complete heart block in infants and children. Chest. 1974;66:639–641
  107. Bruckheimer E, Berul CI, Kopf GS, et al. Late recovery of surgically-induced atrioventricular block in patients with congenital heart disease. J Interv Card Electrophysiol. 2002;6:191–195
  108. Batra AS, Wells WJ, Hinoki KW, et al. Late recovery of atrioventricular conduction after pacemaker implantation for complete heart block associated with surgery for congenital heart disease. J Thorac Cardiovasc Surg. 2003;125:1291–1293
  109. Goldman BS, Williams WG, Hill T, et al. Permanent cardiac pacing after open heart surgery: congenital heart disease. Pacing Clin Electrophysiol. 1985;8:732–739
  110. Kalman JM, VanHare GF, Olgin JE, et al. Ablation of “incisional” reentrant atrial tachycardia complicating surgery for congenital heart disease. Circulation. 1996;93:502–512
  111. Garson A, Bink-Boelkens M, Hesslein PS, et al. Atrial flutter in the young: a collaborative study of 380 cases. J Am Coll Cardiol. 1985;6:871–878
  112. Stranton MS, Miles WM, Zipes DP. Atrial fibrillation and flutter. In:  Zipes DP,  Jalifé J editor. Cardiac Electrophysiology. Philadelphia: WB Saunders; 1990;
  113. Gillette PC, Garson A. Electrophysiologic and pharmacologic characteristics of automatic ectopic atrial tachycardia. Circulation. 1977;56(4 Pt. 1):571–575
  114. Case CL, Gillete PC. Automatic atrial and junctional tachycardias in the pediatric patients (Strategies for diagnosis and management [review]). Pacing Clin Electrophysiol. 1993;16:1323–1355
  115. Villain E, Vetter VL, Garcia JM, et al. Evolving concepts in the management of congenital junctional ectopic tachycardia (A multicenter study [review]). Circulation. 1990;81:1544–1549
  116. Perry JC, Knilans TK, Marlow D, et al. Intravenous amiodarone for life threatening tachyarrhythmias in children and young adults. J Am Coll Cardiol. 1993;22:95–98
  117. Paul T, Ziemer G, Luhmer L, et al. Early and late atrial dysrhythmias after modified Fontan operation. Pediatr Med Chir. 1998;20:9–11
  118. Parry AJ, McElhinney DB, Kung GC, et al. Elective primary repair of acyanotic tetralogy of Fallot in early infancy: overall outcome and impact on the pulmonary valve. J Am Coll Cardiol. 2000;36:2279–2283
  119. Manning PB, Mayer JE, Wernovsky G, et al. Staged operation to Fontan increases the incidence of sinoatrial node dysfunction. J Thorac Cardiovasc Surg. 1996;111:833–839discussion 839-40
  120. Kaulitz R, Ziemer G, Luhmer I, et al. Modified Fontan operation in functionally univentricular hearts: preoperative risk factors and intermediate results. J Thorac Cardiovasc Surg. 1996;112:658–664
  121. Dodge-Khatami A, Miller OI, Anderson RH, et al. Surgical substrates of postoperative junctional ectopic tachycardia in congenital heart defects. J Thorac Cardiovasc Surg. 2002;123:624–630
  122. Dietl CA, Cazzaniga ME, Dubner SJ, et al. Life-threatening arrhythmias and RV dysfunction after surgical repair of tetralogy of Fallot (Comparison between transventricular and transatrial approaches). Circulation. 1994;90(5 Pt. 2):II7–II12
  123. Amodeo A, Galletti L, Marianeschi S, et al. Extracardiac Fontan operation for complex cardiac anomalies: seven years' experience. J Thorac Cardiovasc Surg. 1997;114:1020–1030discussion 1030-1
  124. Hoffman TM, Bush DM, Wernovsky G, et al. Postoperative junctional ectopic tachycardia in children: incidence, risk factors, and treatment. Ann Thorac Surg. 2002;74:1607–1611
  125. Kovacikova L, Hakacova N, Dobos D, et al. Amiodarone as a first-line therapy for postoperative junctional atrial tachycardia. Ann Thorac Surg. 2009;88:616–622
  126. Smerup M, Hjertholm T, Johnsen SP, et al. Pacemaker implantation after congenital heart surgery: risk and prognosis in a population-based follow-up study. Eur J Cardiothorac Surg. 2005;28:61–68
  127. Watson K. Ventilatory support of newborn and pediatric patients. In:  Pilbeam SP editors. Mechanical Ventilation: Physiological and Clinical Applications. St Louis: Mosby; 1998;p. 347–384
  128. Kissoon N, Rimensberger PC, Bohn D. Ventilation strategies and adjunctive therapy in severe lung disease [review]. Pediatr Clin North Am. 2008;55:709–733xii
  129. Rappaport SH, Shpiner R, Yoshihara G, et al. Randomized, prospective trial of pressure-limited versus volume-controlled ventilation in severe respiratory failure. Crit Care Med. 1994;22:22–32
  130. Muñoz J, Guerrero JE, Escalante JL, et al. Pressure-controlled ventilation versus controlled mechanical ventilation with decelerating inspiratory flow. Crit Care Med. 1993;21:1143–1148
  131. Markström AM, Lichtwarck-Aschoff M, Svensson BA, et al. Ventilation with constant versus decelerating inspiratory flow in experimentally induced acute respiratory failure. Anesthesiology. 1996;84:882–889
  132. Davis K, Branson RD, Campbell RS, et al. Comparison of volume control and pressure control ventilation: is flow waveform the difference?. J Trauma. 1996;41:808–814
  133. Al-Saady N, Bennett ED. Decelerating inspiratory flow waveform improves lung mechanics and gas exchange in patients on intermittent positive-pressure ventilation. Intensive Care Med. 1985;11:68–75
  134. Abraham E, Yoshihara G. Cardiorespiratory effects of pressure controlled ventilation in severe respiratory failure. Chest. 1990;98:1445–1449
  135. Schultz TR, Costarino AT, Durning SM, et al. Airway pressure release ventilation in pediatrics. Pediatr Crit Care Med. 2001;2:243–246
  136. Krishnan J, Morrison W. Airway pressure release ventilation: a pediatric case series. Pediatr Pulmonol. 2007;42:83–88
  137. Shekerdemian LS, Shore DF, Lincoln C, et al. Negative-pressure ventilation improves cardiac output after right heart surgery. Circulation. 1996;94:II49–II55
  138. Shekerdemian LS, Bush A, Shore DF, et al. Cardiopulmonary interactions after Fontan operations: augmentation of cardiac output using negative pressure ventilation. Circulation. 1997;2:3934–3942
  139. Engelman RM, Rousou JA, Flack JE, et al. Fast-track recovery of the coronary bypass patient. Ann Thorac Surg. 1994;58:1742–1746
  140. Laussen PC, Roth SJ. Fast tracking: efficiently and safely moving patients through the intensive care unit. Prog Pediatr Cardiol. 2003;18:149–158
  141. Neirotti RA, Jones D, Hackbarth R, et al. Early extubation in congenital heart surgery. Heart Lung Circ. 2002;11:157–161
  142. Ip P, Chiu CS, Cheung YF. Risk factors prolonging ventilation in young children after cardiac surgery: impact of noninfectious pulmonary complications. Pediatr Crit Care Med. 2002;3:269–274
  143. Antón-Pacheco JL, Cano I, García A, et al. Management of congenital tracheomalacia: a single institution experience. Cir Pediatr. 2006;19:55–60
  144. Filler RM, Messineo A, Vinograd I. Severe trachomalacia associated with esophageal atresia: results of surgical treatment. J Pediatr Surg. 1992;27:1136–1141discussion 1134-5
  145. Morabito A, MacKinnon E, Alizai E, et al. The anterior mediastinal approach for management of tracheomalacia. J Pediatr Surg. 2000;35:1456–1458
  146. Ahel V, Banac S, Rozmanić V, et al. Aortopexy and bronchopexy for the management of severe tracheomalacia and bronchomalacia. Pediatr Int. 2003;45:104–106
  147. Pillai JB, Smith J, Spencer D. Review of pediatric airway malacia and its management, with emphasis on stenting [review]. Eur J Cardiothorac Surg. 2005;27:35–44
  148. Antón-Pacheco JL, Cabezalí D, Tejedor R, et al. The role of airway stenting in pediatric tracheobronchial obstruction. Eur J Cardiothorac Surg. 2008;33:1069–1075
  149. Truong MT, Messner AH, Kerschner JE, et al. Pediatric vocal fold paralysis after cardiac surgery: rate of recovery and sequelae. Otolaryngol Head Neck Surg. 2007;137:780–784
  150. Skinner ML, Halstead LA, Rubinstein CS, et al. Laryngopharyngeal dysfunction after the Norwood procedure. J Thorac Cardiovasc Surg. 2005;130:1293–1301
  151. Baker CJ, Boulom V, Reemtsen BL, et al. Hemidiaphragm plication after repair of congenital heart defects in children: quantitative return of diaphragm function over time. J Thorac Cardiovasc Surg. 2008;135:56–61
  152. Lemmer J, Stiller B, Heise G, et al. Postoperative phrenic nerve palsy: early clinical implications and management. Intensive Care Med. 2006;32:1227–1233
  153. Baumeister BL, el-Khatib M, Smith PG, et al. Evaluation of predictors of weaning from mechanical ventilation in pediatric patients. Pediatr Pulmonol. 1997;24:344–352
  154. Argent AC, Newth CJ, Klein M. The mechanics of breathing in children with acute severe croup. Intensive Care Med. 2008;34:324–332
  155. Gozal D, Shoseyov D, Keens TG. Inspiratory pressures with CO2 stimulation and weaning from mechanical ventilation in children. Am Rev Respir Dis. 1993;147:256–261
  156. Khan N, Brown A, Venkataraman ST. Predictors of extubation success and failure in mechanically ventilated infants and children. Crit Care Med. 1996;24:1568–1579
  157. Newth CJ, Venkataraman S, Willson DF, et al. Weaning and extubation readiness in pediatric patients. Pediatr Crit Care Med. 2009;10:1–11
  158. Wypij D, Newburger JW, Rappaport LA, et al. The effect of duration of deep hypothermic circulatory arrest in infant heart surgery on late neurodevelopment: the Boston circulatory arrest trial. J Thorac Cardiovasc Surg. 2003;126:1397–1403
  159. Wernovsky G, Shillingford AJ, Gaynor JW. Central nervous systems outcomes in children with complex congenital heart disease. Curr Opin Cardiol. 2005;20:94–99
  160. Shillingford AJ, Glanzman MM, Ittenbach RF, et al. Inattention, hyperactivity, and school performance in a population of school-age children with complex congenital heart disease. Pediatrics. 2008;121:e759–e767
  161. Karl TR, Hall S, Ford G, et al. Arterial switch with full-flow cardiopulmonary bypass and limited circulatory arrest: neurodevelopmental outcome. J Thorac Cardiovasc Surg. 2004;127:213–222
  162. Chen J, Zimmerman RA, Jarvik GP, et al. Perioperative stroke in infants undergoing open heart operations for congenital heart disease. Ann Thorac Surg. 2009;88:823–829
  163. Bellinger DC, Wypij D, duPlessis AJ, et al. Neurodevelopmental status at eight years in children with dextro-transposition of the great arteries: the Boston circulatory arrest trial. J Thorac Cardiovasc Surg. 2003;126:1385–1396
  164. Kinney HC, Panigrahy A, Newburger JW, et al. Hypoxic-ischemic brain injury in infants with congenital heart disease dying after cardiac surgery. Acta Neuropathol. 2005;110:563–578
  165. Stickle S, Brewer ED, Goldstein SL. Pediatric (PED) acute renal failure (ARF) update: epidemiology and outcome from a three and one half year experience [abstract]. J Am Soc Nephrol. 2002;13:649
  166. Buchman TE, McBryde KD, Mottes TE, et al. Pediatric acute renal failure: outcome by modality and disease. Pediatr Nephrol. 2001;16:1067–1071
  167. Zappitelli M. Epidemiology and diagnosis of acute kidney injury. Semin Nephrol. 2008;28:436–446
  168. Sorof JM, Stromberg D, Brewer ED, et al. Early initiation of peritoneal dialysis after surgical repair of congenital heart disease. Pediatr Nephrol. 1999;13:641–645
  169. Picca S, Principato F, Mazzera E, et al. Risks of acute renal failure after cardiopulmonary bypass surgery in children: a retrospective 10-year case-control study. Nephrol Dial Transplant. 1995;10:630–636
  170. Bailey D, Phan V, Litalien C, et al. Risk factors of acute renal failure in critically ill children: a prospective descriptive epidemiological study. Pediatr Crit Care Med. 2007;8:29–35
  171. Rosner MH, Okusa MD. Acute kidney injury associated cardiac surgery [review]. Clin J Am Soc Nephrol. 2006;1:19–32
  172. Dittrich S, Haas NA, Bührer C, et al. Renal impairment in patients with long-standing cyanotic congenital heart disease. Acta Paediatr. 1998;87:949–954
  173. Inatomi J, Matsouka K, Fujimaru R, et al. Mechanisms of development and progression of cyanotic nephropathy. Pediatr Nephrol. 2006;21:1440–1445
  174. Torre-Amione G, Kapadia S, Benedict C, et al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol. 1996;27:1201–1206
  175. Lazenby WD, Ko W, Zelano JA, et al. Effects of temperature and flow rate on regional blood flow and metabolism during cardiopulmonary bypass. Ann Thorac Surg. 1992;53:957–964
  176. Doberneck RC, Reiser MP, Lillehei CW. Acute renal failure after open-heart surgery utilizing extracorporeal circulation and total body perfusion (Analysis of 1000 patients). J Urol Nephrol. 1962;43:441–452
  177. Lema G, Vogel A, Canessa R, et al. Renal function and cardiopulmonary bypass in pediatric cardiac surgical patients. Pediatr Nephrol. 2006;21:1446–1451
  178. Alkan T, Akçevin A, Türkoglu H, et al. Postoperative prophylactic peritoneal dialysis in neonates and infants after complex congenital cardiac surgery. ASAIO J. 2006;52:693–697
  179. Goldstein SL, Hackbarth R, Bunchman TE, et al. Evaluation of the PRISMA M10 circuit in critically ill infants with acute kidney injury: a report from the Prospective Pediatric CRRT Registry Group. Int J Artif Organs. 2006;29:1105–1108
  180. Hoffman TM, Monroe DM. Coagulation 2006: a modern view of hemostasis. Hematol Oncol Clin North Am. 2007;21:1–11
  181. Bhatt K, Cherian S, Agarwal R, et al. Perioperative management of sickle cell disease in paediatric cardiac surgery. Anaesth Intensive Care. 2007;35:792–795
  182. Baldwin ZK, Spitzer AL, Ng VL, et al. Contemporary standards for the diagnosis and treatment of heparin-induced thrombocytopenia (HIT) [review]. Surgery. 2008;143:305–312
  183. Székely A, Cserép Z, Sápi E, et al. Risks and predictors of blood transfusion in pediatric patients undergoing open heart operations. Ann Thorac Surg. 2009;87:187–197
  184. Fasano R, Luban NL. Blood component therapy [review]. Pediatr Clin North Am. 2008;55:421–445ix
  185. Ferraris VA, Ferraris SP, Saha SP, et al. Perioperative blood transfusion and blood conservation in cardiac surgery: the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists clinical practice guideline. Ann Thorac Surg. 2007;83:S27–S86
  186. Fergusson DA, Hébert PC, Mazer CD, et al. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. N Engl J Med. 2008;358:2319–2331
  187. Hughes DB, Ullery BW, Barie PS. The contemporary approach to the care of Jehovah's witnesses. J Trauma. 2008;65:237–247
  188. Engelman R, Shahian D, Shemin R, et al. The Society of Thoracic Surgeons practice guidelines series: antibiotic prophylaxis in cardiac surgery (Part II: antibiotic choice [review]). Ann Thorac Surg. 2007;83:1569–1576
  189. Edwards FH, Engelman RM, Houck P, et al. The Society of Thoracic Surgeons practice guidelines series: antibiotic prophylaxis in cardiac surgery (Part I: duration). Ann Thorac Surg. 2006;81:397–404
  190. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the national surgical infection prevention project. Am J Surg. 2005;189:395–404
  191. American Society of Health-System Pharmacists. ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 1999;56:1839–1888
  192. Furnary AP, Magovern JA, Simpson KA, et al. Prolonged open sternotomy and delayed sternal closure after cardiac operations. Ann Thorac Surg. 1992;54:233–239
  193. Hashemzadeh K, Hashemzadeh S. In-hospital outcomes of delayed sternal closure after open cardiac surgery. J Card Surg. 2009;24:30–33
  194. Christenson JT, Maurice J, Simonet F, et al. Open chest and delayed sternal closure after cardiac surgery. Eur J Cardiothorac Surg. 1996;10:305–311
  195. Alexi-Meskishvili V, Weng Y, Uhlemann F, et al. Prolonged open sternotomy after pediatric open heart operation: experience with 113 patients. Ann Thorac Surg. 1995;59:379–383
  196. Ruef C, Fanconi S, Nadal D. Sternal wound infection after heart operations in pediatric patients associated with nasal carriage of Staphylococcus aureus. J Thorac Cardiovasc Surg. 1996;112:681–686
  197. Botto LD, May K, Fernhoff PM, et al. A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics. 2003;112(1 Pt. 1):101–107
  198. McDonald-McGinn DM, LaRossa D, Goldmuntz E, et al. The 22q11.2 deletion: screening, diagnostic workup, and outcome of results; report on 181 patients. Genet Test. 1997;1:99–108
  199. Carotti A, Digilio MC, Piacentini G, et al. Cardiac defects and results of cardiac surgery in 22q11.2 deletion syndrome. Dev Disabil Res Rev. 2008;14:35–42
  200. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) system report, data summary from 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32:470–485
  201. Grohskopf LA, Sinkowitz-Cochran RL, Garrett DO, et al. A national point-prevalence survey of pediatric intensive care unit-acquired infections in the United States. J Pediatr. 2002;140:432–438
  202. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter related bloodstream infections in the ICU. N Engl J Med. 2006;355:2725–2732
  203. Costello JM, Morrow DF, Graham DA, et al. Systematic intervention to reduce central line-associated bloodstream infection rates in a pediatric cardiac intensive care unit. Pediatrics. 2008;121:915–923
  204. Richards MJ, Edwards JR, Culver DH, et al. Nosocomial infections in pediatric intensive care units in the United States (Nosocomial infections surveillance system). Pediatrics. 1999;103:e39
  205. Srinivasan R, Asselin J, Gildengorin G, et al. A prospective study of ventilator-associated pneumonia in children. Pediatrics. 2009;123:1108–1115
  206. Curley MA, Schwalenstocker E, Deshpande JK, et al. Tailoring the institute for health care improvement 100,000 lives campaign to pediatric settings: the example of ventilator-associated pneumonia. Pediatr Clin North Am. 2006;53:1231–1235
  207. Bigham MT, Amato R, Bondurrant P, et al. Ventilator-associated pneumonia in the pediatric intensive care unit: characterizing the problem and implementing a sustainable solution. J Pediatr. 2009;154:582–587
  208. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections. Am J Infect Control. 1988;16:128–140
  209. Nateghian A, Taylor G, Robinson J. Risk factors for surgical site infections following open heart surgery in a Canadian pediatric population. Am J Infect Control. 2004;32:397–401
  210. Mehta PA, Cunningham CK, Colella CB, et al. Risk factor for sternal wound and other infections in pediatric cardiac surgery patients. Pediatr Infect Dis J. 2000;19:1000–1004
  211. Tabbutt S, Duncan BW, McLaughlin D, et al. Delayed sternal closure after cardiac operations in a pediatric population. J Thorac Cardiovasc Surg. 1997;113:886–893
  212. Al-Sehly AA, Robinson JL, Lee BE, et al. Pediatric poststernotomy mediastinitis. Ann Thorac Surg. 2005;80:2314–2320
  213. Long CB, Shah SS, Lautenbach E, et al. Postoperative mediastinitis in children: epidemiology, microbiology and risk factors for gram-negative pathogens. Pediatr Infect Dis J. 2005;24:315–319
  214. Yasuura K, Okamoto H, Morita S, et al. Results of omental flap transposition for deep sternal wound infection after cardiovascular surgery. Ann Thorac Surg. 1998;227:455–459
  215. Reade CC, Meadows WM, Bower CE, et al. Laparoscopic omental harvest in flap coverage in complex mediastinitis. Am Surg. 2003;69:1072–1076
  216. Rand RP, Cochran RP, Aziz S, et al. Prospective trial of catheter irrigation and muscle flaps for sternal wound infection. Ann Thorac Surg. 1998;65:1046–1049
  217. Jones TJ, Elliot MJ. Paediatric CPD: bypass in a high risk group. Perfusion. 2006;21:229–233
  218. Francel TJ, Kouchoukos NT. A rational approach to wound difficulties after sternotomy: the problem. Ann Thorac Surg. 2001;72:1411–1418
  219. El Gamel A, Yonan NA, Hassan R, et al. Treatment of mediastinitis: early modified Robicsek closure and pectoralis major advancement flaps. Ann Thorac Surg. 1998;65:41–46discussion 46-7
  220. Argenta LC, Morykwas MJ. Vacuum assisted closure (A new method for wound control and treatment: clinical experience). Ann Plast Surg. 1997;38:563–577
  221. Ohye RG, Maniker RB, Graves HL, et al. Primary closure for postoperative mediastinitis in children. J Thorac Cardiovasc Surg. 2004;128:480–486
  222. Caniano DA, Ruth B, Teich S. Wound management with vacuum assisted closure: experience in 52 pediatric patients. J Pediatr Surg. 2005;40:128–132
  223. Morykwas MJ, Argenta LC, Shelton-Brown EI, et al. Vacuum assisted closure: a new method for wound control and treatment: animal studies and basic foundation. Ann Plast Surg. 1997;38:553–562
  224. Shay DK, Holman RC, Newman RD, et al. Bronchiolitis-associated hospitalizations among U.S. children, 1980-1996. JAMA. 1999;282:1440–1446
  225. MacDonald NE, Hall CB, Suffin SC, et al. Respiratory syncytial viral infection in infants with congenital heart disease. N Engl J Med. 1982;207:397–400
  226. Navas L, Wang E, de Carvalho V, et al. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children (Pediatric Investigators Collaborative Network on infections in Canada). J Pediatr. 1992;121:348–354
  227. Moler FW, Khan AS, Meliones JN, et al. Respiratory syncytial virus morbidity and mortality estimates in congenital heart disease patients: a recent experience. Crit Care Med. 1992;20:1406–1413
  228. Meissner HC, Long SS American Academy of Pediatrics Committee on infectious diseases and Committee on fetus and newborn. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics. 2003;112:1447–1452
  229. American Academy of Pediatrics. Respiratory syncytial virus. In:  Pickering LK,  Baker CJ,  Long SS, et al. editor. Red Book 2006: Report of the Committee on Infectious Diseases. Elk Grove Village, IL: American Academy of Pediatrics; 2006;p. 560–566
  230. Khongphatthanayothin A, Wong PC, Samara Y, et al. Impact of respiratory syncytial virus infection on surgery for congenital heart disease: postoperative course and outcome. Crit Care Med. 1999;27:1974–1981
  231. Taubert KA, Gewitz M. Infective endocarditis. In:  Allaen DA,  Driscoll DJ,  Shaddy RE, et al. editor. Moss and Adams' Heart Disease in Infants, Children and Adolescents. Philadelphia: Lippincott Williams & Wilkins; 2008;p. 1299–1312
  232. Wilson W, Taubert KA, Gewitz M, et al. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116:1736–1754
  233. Bonow RO, Carabello BA, Chatterjee K, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease) (Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons). J Am Coll Cardiol. 2008;52:e69–e77
  234. Bonow RO, Carabello BA, Chatterjee K, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease) (Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons). J Am Coll Cardiol. 2008;52:e1–e142
  235. Bonow RO, Carabello BA, Chatterjee K, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease) (Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons). J Am Coll Cardiol. 2008;52:e75
  236. Dickerson H, Cooper DS, Checchia PA, et al. Endocrinal complications associated with the treatment of patients with congenital cardiac disease: consensus definitions from the Multi-Societal Database Committee for pediatric and congenital heart disease. Cardiol Young. 2008;18:256–264
  237. Trimarchi T. Endocrine problems in critically ill children: an overview. AACN Clin Issues. 2006;17:66–78
  238. Guyton AC, Hall JE. Endocrinology and reproduction. In:  Guyton AC,  Hall JE editor. Textbook of Medical Physiology. Philadelphia: Saunders; 2005;p. 905–976
  239. Henzen C, Kobza R, Schwaller-Protzmann B, et al. Adrenal function during coronary artery bypass grafting. Eur J Endocrinol. 2003;148:663–668
  240. Dönmez A, Kaya H, Haberal A, et al. The effect of etomidate induction on plasma cortisol levels in children undergoing cardiac surgery. J Cardiothorac Vasc Anesth. 1998;12:182–185
  241. Absalom A, Pledger D, Kong A. Adrenocortical function in critically ill patients 24 h after a single dose of etomidate. Anaesthesia. 1999;54:861–867
  242. Chrousos GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med. 1995;332:1351–1362
  243. Annane D, Sébille V, Troché G, et al. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to cosyntropin. JAMA. 2000;283:1038–1045
  244. Sajan I, Dent C, Schwartz SM, et al. Adrenal dysfunction is common in children with congenital heart disease manifesting catecholamine-refractory low cardiac output syndrome. Crit Care Med. 2004;32:A6
  245. Pizzaro CF, Troster EJ, Damiani D, et al. Absolute and relative adrenal insufficiency in children with septic shock. Crit Care Med. 2005;33:855–859
  246. Oppert M, Schindler R, Husung C, et al. Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock. Crit Care Med. 2005;33:2457–2464
  247. Oppert M, Reinicke A, Gräf KJ, et al. Plasma cortisol level before and during “low-dose” hydrocortisone therapy and their relationship to hemodynamic improvement in patients with septic shock. Intensive Care Med. 2000;26:1747–1755
  248. Yen PM. Physiological and molecular basis of thyroid hormone action. Physiol Rev. 2001;81:1097–1142
  249. Van den Berghe G, de Zegher F, Lauwers P. Dopamine and the sick euthyroid syndrome in critical illness. Clin Endocrinol (Oxf). 1994;41:731–737
  250. Adriaanse R, Romijn JA, Brabant G, et al. Pulsatile thyrotropin secretion in nonthyroidal illness. J Clin Endocrinol Metab. 1993;77:1313–1317
  251. Romijn JA, Wiersinga WM. Decreased nocturnal surge of thyrotropin in nonthyroidal illness. J Clin Endocrinol Metab. 1990;70:35–42
  252. Duntas LH, Nguyen TT, Keck FS, et al. Changes in metabolism of TRH in euthyroid sick syndrome. Eur J Endocrinol. 1999;141:337–341
  253. Bellabarba D, Inada M, Varsano-Aharon N, et al. Thyroxine transport and turnover in major nonthyroidal illness. J Clin Endocrinol Metab. 1968;28:1023–1030
  254. Robbins J. Thyroid hormone transport proteins and the physiology of thyroid hormone binding. In:  Braverman LE,  Utiger RD editor. Werner and Ingbar's the Thyroid. Philadelphia: Lippincott Williams & Wilkins; 2000;p. 105–120
  255. Kaptein EM, Grieb DA, Spencer CA, et al. Thyroxine metabolism in the low thyroxine state of critical nonthyroidal illnesses. J Clin Endocrinol Metab. 1981;53:764–771
  256. Afandi B, Schussler GC, Arafeh AH, et al. Selective consumption of thyroxine-binding globulin during cardiac bypass surgery. Metabolism. 2000;49:270–274
  257. Lim CF, Munro SL, Wynne KN, et al. Influence of non-esterified fatty acids and lysolecithins on thyroxine binding to thyroxine-binding globulin and transthyretin. Thyroid. 1995;4:319–324
  258. Lim CF, Doctor R, Visser TJ, et al. Inhibition of thyroxine transport into cultured rat hepatocytes by serum of nonuremic critically ill patients: effects of bilirubin and non-esterified fatty acids. J Clin Endocrinol Metab. 1993;76:1165–1172
  259. Jaume JC, Mendel CM, Frost PH, et al. Extremely low doses of heparin release lipase activity into the plasma and can thereby cause artifactual elevations in the serum-free thyroxine concentration as measured by equilibrium dialysis. Thyroid. 1996;6:79–83
  260. Amberson J, Drinka PJ. Medication and low serum thyroxine values in nursing home residents. South Med J. 1998;91:437–440
  261. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344:501–509
  262. Polikar R, Burger AG, Scherrer U, et al. The thyroid and the heart. Circulation. 1993;87:1435–1441
  263. Klein I. Thyroid hormone and the cardiovascular system. Am J Med. 1990;88:631–637
  264. Dillmann WH. Biochemical basis of thyroid hormone action in the heart. Am J Med. 1990;88:626–630
  265. Park KW, Dai HB, Ojamaa K, et al. The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries. Anesth Analg. 1997;85:734–738
  266. Saatvedt K, Lindberg H. Depressed thyroid function following paediatric cardiopulmonary bypass: association with interleukin-6 release?. Scand J Thorac Cardiovasc Surg. 1996;30:61–64
  267. Mainwaring RD, Lamberti JJ, Carter TL, et al. Reduction in triiodothyronine levels following modified Fontan procedure. J Card Surg. 1994;9:322–331
  268. Bettendorf M, Schmidt KG, Tiefenbacher U, et al. Transient secondary hypothyroidism in children after cardiac surgery. Pediatr Res. 1997;41:375–379
  269. Dimmick S, Badawi N, Randell T. Thyroid hormone supplementation for the prevention of morbidity and mortality in infants undergoing cardiac surgery. Cochrane Database Syst Rev. 2004;CD004220
  270. Dagan O, Vidne B, Josefsberg Z, et al. Relationship between changes in thyroid hormone level and severity of the postoperative course in neonates undergoing open-heart surgery. Paediatr Anaesth. 2006;16:538–542
  271. Bettendorf M, Schmidt KG, Grulich-Henn J, et al. Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study. Lancet. 2000;356:529–534
  272. Levitt-Katz LE, Stanley C. Disorders of glucose and other sugars. In:  Spitzer AR editors. Intensive Care of the Fetus and Neonate. St Louis: Mosby; 1996;p. 982–992
  273. Stanley CA, Baker L. The causes of neonatal hypoglycemia. N Engl J Med. 1999;340:1200–1201
  274. Taylor KM, Jones JV, Walker MS, et al. The cortisol response during heart-lung bypass. Circulation. 1976;54:20–25
  275. Yeager MP, Rassias AJ, Fillinger MP, et al. Cortisol antiinflammatory effects are maximal at postoperative plasma concentrations. Crit Care Med. 2005;33:1507–1512
  276. Roth-Isigkeit A, Brechmann J, Dibbelt L, et al. Persistent endocrine stress response in patients undergoing cardiac surgery. J Endocrinol Invest. 1998;21:12–19
  277. McKnight CK, Elliott MJ, Pearson DT, et al. The effects of four different crystalloid bypass-priming fluids upon the metabolic response to cardiac operation. J Thorac Cardiovasc Surg. 1985;90:97–111
  278. Kuntschen FR, Galleti PM, Hahn C. Glucose-insulin interactions during cardiopulmonary bypass (Hypothermia versus normothermia). J Thorac Cardiovasc Surg. 1986;91:451–459
  279. Lehot JJ, Piriz H, Villard J, et al. Glucose homeostasis: comparison between hypothermic and normothermic cardiopulmonary bypass. Chest. 1992;102:106–111
  280. Doenst T, Wijeysundera D, Karkouti K, et al. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg. 2005;130:1144
  281. Feerick AE, Johnston WE, Jenkins LW, et al. Hyperglycemia during hypothermic canine cardiopulmonary bypass increases cerebral lactate. Anesthesiology. 1995;82:512–552
  282. Conroy BP, Grafe MR, Jenkins LW, et al. Histopathologic consequences of hyperglycemic cerebral ischemia during hypothermic cardiopulmonary bypass in pigs. Ann Thorac Surg. 2001;71:1325–1334
  283. de-Ferranti S, Gauvreau K, Hickey PR, et al. Intraoperative hyperglycemia during infant cardiac surgery is not associated with adverse neurodevelopmental outcomes at 1, 4, and 8 years. Anesthesiology. 2004;100:1345–1352
  284. Ghanayem NS, Dearani JA, Welke KF, et al. Gastrointestinal complications associated with the treatment of patients with congenital cardiac disease: consensus definitions from the Multi-Societal Database Committee for Pediatric and Congenital Heart Disease. Cardiol Young. 2008;18:240–244
  285. Weesner KM, Rosenthal A. Gastroesophageal reflux in association with congenital heart disease. Clin Pediatr (Phila). 1983;22:424–426
  286. Thompson LD, McElhinney DB, Jue KL, et al. Gastroesophageal reflux after repair of atrioventricular septal defect in infants with trisomy 21: a comparison of medical and surgical therapy. J Pediatr Surg. 1999;34:1359–1362
  287. Goldmuntz E. The genetic contribution to congenital heart disease. Pediatr Clin North Am. 2004;51:1721–1737
  288. Cribbs RK, Heiss KF, Clabby ML, et al. Gastric fundoplication is effective in promoting weight gain in children with severe congenital heart defects. J Pediatr Surg. 2008;43:283–289
  289. Varan B, Tokel K, Yilmaz G. Malnutrition and growth failure in cyanotic and acynaotic congenital heart disease with and without pulmonary hypertension. Arch Dis Child. 1999;81:49–52
  290. Abad-Sinden A, Sutphen JL. Growth and nutrition. In:  Allen HD,  Gutgesell HP,  Clark EB, et al. editor. Heart Disease in Infants, Children, and Adolescents Including the Fetus and Young Adult. Philadelphia: Lippincott Williams and Wilkins; 1991;p. 325–332
  291. Barton JS, Hindmarsh PC, Scrimgeour CM, et al. Energy expenditure in congenital heart disease. Arch Dis Child. 1994;70:5–9
  292. Norris MK, Hill CS. Nutritional issues in infants and children with congenital heart disease. Crit Care Nurs Clin North Am. 1994;6:153–163
  293. Rosenthal A. Nutritional considerations in the prognosis and treatment of children with congenital heart disease. In:  Suskind RM,  Lewinter-Suskind L editor. Textbook of Pediatric Nutrition. New York: Raven Press, Ltd; 1993;p. 383–391
  294. Smith P. Primary care in children with congenital heart disease. J Pediatr Nurs. 2001;16:308–319
  295. Schwarz SM, Gewitz MH, See CC, et al. Enteral nutrition in infants with congenital heart disease and growth failure. Pediatrics. 1990;86:368–373
  296. Schuurmans FM, Pulles-Heintzberger CF, Gerver WJ, et al. Long-term growth of children with congenital heart disease: a retrospective study. Acta Paediatr. 1998;87:1250–1255
  297. Marchand V, Baker SS, Baker RD. Enteral nutrition in the pediatric population. Gastrointest Endosc Clin North Am. 1998;8:669–703
  298. Laussen PC. Neonates with congenital heart disease. Curr Opin Pediatr. 2001;13:220–226
  299. Hannan RL, Ybarra MA, White JA, et al. Patterns of lactate values after congenital heart surgery and timing of cardiopulmonary support. Ann Thorac Surg. 2005;80:1468–1473discussion 1473-4
  300. Kallfelz HC. Congenital heart disease and cardiac surgery in children. Curr Opin Cardiol. 1994;9:103–113
  301. Mavroudis C, Bove EL, Cameron DE, et al. The society of thoracic surgeons' national congenital heart surgery database. Ann Thorac Surg. 1995;59:554–556
  302. Higgins TL, Estafanous FG, Loop FD, et al. Stratification of morbidity and mortality outcome by preoperative risk factors in coronary artery bypass patients: a clinical severity score. JAMA. 1992;267:2344–2348
  303. Higgins TL, Estafanous FG, Loop FD, et al. ICU admission score for predicting morbidity and mortality risk after coronary artery bypass grafting. Ann Thorac Surg. 1997;64:1050–1058
  304. Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure (On behalf of the Working Group on sepsis-related problems of the European society of intensive care medicine). Intensive Care Med. 1996;22:707–710
  305. Ceriani R, Mazzoni M, Bortone F, et al. Application of the sequential organ failure assessment score to cardiac surgical patients. Chest. 2003;123:1229–1239
  306. Shime N, Kageyama K, Ashida H, et al. Application of modified sequential organ failure assessment score in children after cardiac surgery. J Cardiothorac Vasc Anesth. 2001;15:463–468
  307. Carthey J, de Laval MR, Reason JT. The human factor in cardiac surgery: errors and near misses in a high technology medical domain. Ann Thorac Surg. 2001;72:300–305
  308. Catchpole KR, Giddings AE, de Laval MR. Identification of systems failures in successful pediatric cardiac surgery. Ergonomics. 2006;49:567–588
  309. Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients (Results of the Harvard Medical Practice study II). N Engl J Med. 1991;324:377–384
  310. Bates DW, Cullen DJ, Laird N, et al. ADE prevention study group Incidence of adverse drug events and potential adverse drug events (Implications for prevention). JAMA. 1995;274:29–34
  311. Thiagarajan RR, Bird GL, Harrington K, et al. Improving safety for children with cardiac disease. Cardiol Young. 2007;17:127–132
  312. Bognár A, Barach P, Johnson JK, et al. Errors and the burden of errors: attitudes, perceptions, and the culture of safety in pediatric cardiac surgical teams. Ann Thorac Surg. 2008;85:1374–1381
  313. Creaden JA, Kohr LM. The nurse practitioner's role in patient management. In:  Mavroudis C,  Backer CL editor. Pediatric Cardiac Surgery. Philadelphia: Mosby; 2003;p. 143–159
  314. Mackie AS, Gauvreau K, Newburger JW, et al. Risk factors for readmission after neonatal cardiac surgery. Ann Thorac Surg. 2004;78:1972–1978
  315. Te Pas AB, van Wezel-Meijler G, Bökenkamp-Gramann R, et al. Preoperative cranial ultrasound findings in infants with major congenital heart disease. Acta Paediatr. 2005;94:1597–1603
  316. Olsén P, Vainionpää L, Pääkkö E, et al. Psychological findings in preterm children related to neurologic status and magnetic resonance imaging. Pediatrics. 1998;102(2 Pt. 1):329–336
  317. Baffa JM, van Wezel-Meijler G, Bokenkamp-Gramann R, et al. Coronary artery abnormalities and right ventricular histology in hypoplastic left heart syndrome. J Am Coll Cardiol. 1992;20:350–358
  318. Sauer U, Gittenberger-de Groot AC, Geishauser M, et al. Coronary arteries in the hypoplastic left heart syndrome (Histopathologic and histometrical studies and implications for surgery). Circulation. 1989;80:I168–I176
  319. Barnea O, Santamore WP, Rossi A, et al. Estimation of oxygen delivery in newborns with a univentricular circulation. Circulation. 1998;98:1407–1413
  320. Day RW, Barton AJ, Pysher TJ, et al. Pulmonary vascular resistance of children treated with nitrogen during early infancy. Ann Thorac Surg. 1998;65:1400–1404
  321. Ebenroth E. Point: hypoxia is the optimal means of reducing pulmonary blood flow in the preoperative single ventricle heart. J Appl Physiol. 2008;104:1835–1836discussion 1838-9
  322. Jobes DR, Prakash ES, Day RW. Comments on point:counterpoint. J Appl Physiol. 2008;104:1841
  323. Liske MR, Aschner JL. Point: counterpoint: hypoxia is/is not the optimal means of reducing pulmonary blood flow in the preoperative single ventricle heart. J Appl Physiol. 2008;104:1836–1838discussion 1838-9
  324. Liske MR, Aschner JL. Last word on point:counterpoint: hypoxia is/is not the optimal means of reducing pulmonary blood flow in the preoperative single ventricle heart. J Appl Physiol. 2008;104:1843
  325. Tabbutt S, Ramamoorthy C, Montenegro LM, et al. Impact of inspired gas mixtures on preoperative infants with hypoplastic left heart syndrome during controlled ventilation. Circulation. 2001;104(12 suppl 1):I159–I164
  326. Yildiz M. Comment on point: counterpoint: hypoxia is/is not the optimal means of reducing pulmonary blood flow in the preoperative single ventricle heart. J Appl Physiol. 2008;105:1371
  327. Rubin LJ American College of Chest Physicians. Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004;126(suppl 1):4S–6
  328. Rich S. The current treatment of pulmonary hypertension: time to redefine success [review]. Chest. 2006;130:1198–1202
  329. Gandhi SK, Grady RM, Huddleston CB, et al. Beyond Berlin: heart transplantation in the “untransplantable”. J Thorac Cardiovasc Surg. 2008;136:529–531
  330. Badesch DB, Abman SH, Ahearn GS, et al. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest. 2004;126(suppl 1):35S–62
  331. Raja SG, Nayak SH. Sildenafil: emerging cardiovascular indications. Ann Thorac Surg. 2004;78:1496–1506
  332. Tsai BM, Wang M, Turrentine MW, et al. Hypoxic pulmonary vasoconstriction in cardiothoracic surgery: basis mechanisms to potential therapies. Ann Thorac Surg. 2004;78:360–368
  333. Chrisostomou C, Di Filippo S, Manrique AM, et al. Use of dexmedetomidine in children after cardiac and thoracic surgery. Pediatr Crit Care Med. 2006;7:126–131
  334. Fricker FJ. Cardiac transplantation. In:  Fuhrman BP,  Zimmerman JJ editor. Pediatric Critical Care. Philadelphia: Mosby/Elsevier; 2006;p. 465–474
  335. Webber SA, McCurry K, Zeevi A. Heart and lung transplantation in children. Lancet. 2006;368:53–69
  336. Chinnock RE, Pearce FB. Pediatric heart transplantation. In:  Kirklin JK,  Young JB,  McGiffin DC editor. Heart Transplantation. New York: Churchill Livingstone; 2002;p. 717–770
  337. White-Williams C. Quality of life after heart transplantation. In:  Kirklin JK,  Young JB,  McGiffin DC editor. Heart Transplantation. New York: Churchill Livingstone; 2002;p. 703–713
  338. Simmonds J, Burch M, Dawkins H, et al. Heart transplantation after congenital heart surgery: improving results and future goals. Eur J Cardiothorac Surg. 2008;34:313–317
  339. Naftel DC, Kirklin JK, Hsu DT, et al. Pediatric heart transplantation: 14 years of improving results illustrated by patient specific predictions. J Heart Lung Transplant. 2008;27(2 suppl 1):S253–S254
  340. Duncan BW, Burch M, Kirklin JK, et al. Management of patients awaiting transplantation: medical, immunologic and mechanical support. In:  Canter CE,  Kirklin JK editor. Pediatric Heart Transplantation. Philadelphia: Elsevier; 2007;p. 33–54
  341. Boucek MM, Waltz DA, Edwards LB, et al. Registry of the international society for heart and lung transplantation: ninth official pediatric heart transplantation report—2006. J Heart Lung Transplant. 2006;25:893–903
  342. Lipshultz SE, Sleeper LA, Towbin JA, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med. 2003;348:1647–1655
  343. Nugent AW, Daubeney PE, Chondros P, et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med. 2003;348:1639–1646
  344. Canter CE, Naftel DC. Recipient characteristics: heart transplantation. In:  Fine RN,  Webber SA,  Olthoff KM, et al. editor. Pediatric Solid Organ Transplantation. Oxford: Blackwell; 2009;
  345. Towbin JA, Lowe AM, Colan SD, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA. 2006;296:1867–1876
  346. Canter CE, Shaddy RE, Bernstein D, et al. Indications for heart transplantation in pediatric heart disease. Circulation. 2007;115:658–676
  347. Lamour JM, Kanter KR, Naftel DC, et al. The effect of age, diagnosis, and previous surgery in 488 children and adults who undergo heart transplantation for congenital heart disease. J Am Coll Cardiol. 2009;54:160–165
  348. Michielon G, Parisi F, Di Carlo D, et al. Orthotopic heart transplantation for failing single ventricle physiology. Eur J Cardiothorac Surg. 2003;24:502–510discussion 510
  349. Mital S, Addonizio LJ, Lamour JM, et al. Outcome of children with end-stage congenital heart disease waiting for cardiac transplantation. J Heart Lung Transplant. 2003;22:147–153
  350. Krams R, McFalls E, van der Giessen WJ, et al. Does intravenous milrinone has a direct effect on diastolic function. Am Heart J. 1991;121(6 Pt. 2):1951–1955
  351. Monrad ES, McKay RG, Baim DS, et al. Improvement in indexes of diastolic performance in patients with congestive heart failure treated with milrinone. Circulation. 1984;70:1030–1037
  352. Rosenthal DN, Dubin AM, Chin C, et al. Outcome while awaiting heart transplantation in children: a comparison of congenital heart disease and cardiomyopathy. J Heart Lung Transplant. 2000;19:751–755
  353. Price JF, Towbin JA, Dreyer WJ, et al. Outpatient continuous inotropic therapy as a bridge to transplantation in children with advanced heart failure. J Card Fail. 2006;12:139–143
  354. Reek S, Geller JC, Meltendorf U, et al. Clinical efficacy of a wearable defibrillator in acutely terminating episodes of ventricular fibrillation using biphasic shocks. Pacing Clin Electrophysiol. 2003;26:2016–2022
  355. Dreyer W. Congestive heart failure. In:  McNammara D editors. The Science and Practice of Pediatric Cardiology. Philadelphia: Lea and Febiger; 1990;p. 2007–2023
  356. del Nido PJ, Bailey LL, Kirklin JK. Surgical techniques in pediatric heart transplantation. In:  Canter CE,  Kirklin JK editor. Pediatric Heart Transplantation ISHLT Monograph Series. Philadelphia: Elsevier; 2007;p. 83–102
  357. Doty DB, Renlund DG, Caputo GR, et al. Cardiac transplantation in situs inversus. J Thorac Cardiovasc Surg. 1990;99:493–499
  358. Michler RE, Sandhu AA. Novel approach for orthotopic heart transplantation in visceroatrial situs inversus. Ann Thorac Surg. 1995;60:194–197
  359. Parry AJ, O'Fiesh J, Wallwork J, et al. Heart-lung transplantation in situs inversus and chest wall deformity. Ann Thorac Surg. 1994;58:1174–1176
  360. Rubay JE, d'Udekem Y, Sluysmans T, et al. Orthotopic heart transplantation in situs inversus. Ann Thorac Surg. 1995;60:460–462
  361. Vricella LA, Razzouk AJ, Gaundry SR, et al. Heart transplantation in infants and children with situs inversus. J Thorac Cardiovasc Surg. 1998;116:82–89
  362. Huang J, Trinkaus K, Huddleston CB, et al. Risk factors for primary graft failure after pediatric cardiac transplantation: importance of recipient and donor characteristics. J Heart Lung Transplant. 2004;23:716–722
  363. Scheule AM, Zimmerman GJ, Johnston JK, et al. Duration of graft cold ischemia does not affect outcomes in pediatric heart transplant recipients. Circulation. 2002;106(12 suppl I):I163–I167
  364. Costanzo-Nordin MR, Liao Y, Grusk BB, et al. Oversizing of donor hearts: beneficial or detrimental?. J Heart Lung Transplant. 1991;10(5 Pt. 1):717–730
  365. Tamisier D, Vouhé P, Le Bidois J, et al. Donor-recipient size matching in pediatric heart transplantation: a word of caution about small grafts. J Heart Lung Transplant. 1996;15:190–195
  366. Tweddell JS, Canter CE, Bridges ND, et al. Predictors of operative mortality and morbidity after infant heart transplantation. Ann Thorac Surg. 1994;58:972–977
  367. Yeoh TK, Frist WH, Lagerstrom C, et al. Relationship of cardiac allograft size and pulmonary vascular resistance to long-term cardiopulmonary function. J Heart Lung Transplant. 1992;11:1168–1172
  368. de Begona JA, Gundry SR, Razzouk AJ, et al. Transplantation of hearts after arrest and resuscitation. J Thorac Cardiovasc Surg. 1993;106:1196–1201discussion 1200-1
  369. Chinnock RE, Larsen RL, Emery JR, et al. Pretransplant risk factors and causes of death or graft loss after heart transplantation during early infancy. Circulation. 1995;92(suppl):II206–II209
  370. Chugh R, Marelli D, Child JS, et al. Heart transplantation in adolescents and adults with congenital heart disease [abstract]. J Am Coll Cardiol. 2002;40:401A
  371. Hsu DT, Quaegebeur JM, Michler RE, et al. Heart transplantation in children with congenital heart disease. J Am Coll Cardiol. 1995;26:743–749
  372. Holt DB, Lublin DM, Phelan DL, et al. Rejection in presensitized pediatric heart transplant recipients with a positive cross match utilizing perioperative plasmapheresis and cytolytic therapy [abstract]. J Heart Lung Transplant. 2005;24:S113
  373. Jacobs JP, Quintessenza JA, Boucek RJ, et al. Pediatric cardiac transplantation in children with high panel reactive antibody. Ann Thorac Surg. 2004;78:1703–1709
  374. Leech SH, Lopez-Cepero M, LeFor WM, et al. Management of the sensitized cardiac recipient: the use of plasmapheresis and intravenous immunoglobulin. Clin Transplant. 2006;20:476–484
  375. Pisani BA, Mullen GM, Malinowska K, et al. Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplantation. J Heart Lung Transplant. 1999;18:701–706
  376. Ardehali A, Hughes K, Sadeghi A, et al. Inhaled nitric oxide for pulmonary hypertension after heart transplantation. Transplantation. 2001;72:638–641
  377. Allen EM, van Heeckern DW, Spector ML, et al. Management of nutritional and infectious complications of postoperative chylothorax in children. J Pediatr Surg. 1991;26:1169–1174
  378. Chan EH, Russell JL, Williams WG, et al. Postoperative chylothorax after pediatric cardiac surgery in children. Ann Thorac Surg. 2005;80:1864–1870
  379. Nguyen DM, Shum-Tim O, Dobell AR, et al. The management of chylothorax/chylopericardium following pediatric cardiac surgery: a 10-year experience. J Card Surg. 1995;10:302–308
  380. Comrack BE, Wilson NJ, Finucane K, et al. Use of monogen for pediatric postoperative chylothorax. Ann Thorac Surg. 2004;77:301–305
  381. Cannizzaro V, Frey B, Bernet-Buettiker V. The role of somatostatin in the treatment of persistent chylothorax in children. Eur J Cardiothorac Surg. 2006;30:49–53
  382. Chan SY, Lau W, Wong WH, et al. Chylothorax in children after congenital heart surgery. Ann Thorac Surg. 2006;82:1650–1657
  383. Beghetti M, La Scala G, Belli D, et al. Etiology and management of pediatric chylothorax. J Pediatr. 2000;136:653–658
  384. Le Coultre C, Oberhänsli I, Mossaz A, et al. Postoperative chylothorax in children: differences between vascular and traumatic origin. J Pediatr Surg. 1991;26:519–523
  385. Bridges ND, Mayer JE, Lock JE, et al. Effect of baffle fenestration on outcome of the modified Fontan operation. Circulation. 1992;86:1762–1769
  386. Gentles TL, Mayer JE, Gauvreau K, et al. Fontan operation in five hundred consecutive patients: factors influencing early and late outcome. J Thorac Cardiovasc Surg. 1997;114:376–391
  387. Petrossian E, Reddy VM, McElhinney DB, et al. Early results of the extracardiac conduit Fontan operation. J Thorac Cardiovasc Surg. 1999;117:688–696
  388. Azakie A, McCrindle BW, Van Arsdell G, et al. Extracardiac conduit versus lateral tunnel cavopulmonary connections at a single institution: impact on outcomes. J Thorac Cardiovasc Surg. 2001;122:1219–1228
  389. Atik E, Ikari NM, Martins TC, et al. Fontan operation and the cavopulmonary technique: immediate and late results according to the presence of atrial fenestration. Arq Bras Cardiol. 2002;78:162–166
  390. Berman W, Fripp RR, Yabek SM, et al. Great vein and right atrial thrombosis in critically ill infant and children with central venous lines. Chest. 1991;99:963–967
  391. Dhande V, Kattwinkel J, Alford B. Recurrent bilateral pleural effusion secondary to superior vena cava obstruction as a complication of central venous catheterization. Pediatrics. 1983;72:109–113
  392. Buttiker V, Fanconi S, Burger R. Chylothorax in children: guidelines for diagnosis and management. Chest. 1999;116:682–687
  393. Rimensberger PC, Muller-Schenker B, Kalangos A, et al. Treatment of a persistent postoperative chylothorax with somatostatin. Ann Thorac Surg. 1998;66:253–254
  394. Lam JC, Aters S, Tobias JD. Initial experience with octreotide in the pediatric population. Am J Ther. 2001;8:409–415
  395. Tibballs J, Soto R, Bharucha T. Management of newborn lymphangiectasia and chylothorax after cardiac surgery with octreotide infusion. Ann Thorac Surg. 2004;77:2213–2215
  396. Lamberts SW, van der Lely AJ, de Herder WW, et al. Octreotide. N Engl J Med. 1996;334:246–254
  397. Ulíbarri JI, Sanz Y, Fuentes C, et al. Reduction of lymphorrhagia from ruptured thoracic duct by somatostatin. Lancet. 1990;336:258
  398. Cheung Y, Leung MP, Yip M. Octreotide for treatment of postoperative chylothorax. J Pediatr. 2001;139:157–159
  399. Pratap U, Slavik Z, Ofoe VD, et al. Octreotide to treat postoperative chylothorax after cardiac operations in children. Ann Thorac Surg. 2001;72:1740–1742
  400. Mohseni-Bod H, Macrae D, Slavik Z. Somatostatin analog (octreotide) in management of neonatal postoperative chylothorax: is it safe?. Pediatr Crit Care Med. 2004;5:356–357
  401. Lim KA, Kim SH, Huh J, et al. Somatostatin for postoperative chylothorax after surgery for children with congenital heart disease. J Korean Med Sci. 2005;20:947–951
  402. Rosti L, De Battisti F, Butera G, et al. Octreotide in the management of postoperative chylothorax. Pediatr Cardiol. 2005;26:440–443
  403. Roehr CC, Jung A, Proquitté H, et al. Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review. Intensive Care Med. 2006;32:650–657
  404. Hamdan MA, Gaeta ML. Octreotide and low-fat breast milk in postoperative chylothorax. Ann Thorac Surg. 2004;77:2215–2217
  405. Rasiah SV, Oei J, Lui K. Octreotide in the treatment of congenital chylothorax. J Paediatr Child Health. 2004;40:585–588
  406. Paget-Brown A, Kattwinkel J, Rodgers BM, et al. The use of octreotide to treat congenital chylothorax. J Pediatr Surg. 2006;41:845–847
  407. Mohan H, Paes ML, Haynes S. Use of intravenous immunoglobulins as an adjunct in the conservative management of chylothorax. Paediatr Anaesth. 1999;9:89–92
  408. François K, Bové T, De Groote K, et al. Pleural effusions, water balance mediators and the influence of lisinopril after completion Fontan procedures. Eur J Cardiothorac Surg. 2009;36:57–62
  409. Bernet-Buettiker V, Waldvogel K, Cannizzaro V, et al. Antithrombin activity in children with chylothorax. Eur J Cardiothorac Surg. 2006;29:406–409
  410. McBride ME, Drass JC, Berkenbosch JW, et al. Hypogammaglobulinemia complicating chylothorax after cardiac surgery in two infants. J Cardiothorac Vasc Anesth. 2001;15:358–361
  411. Nath DS, Savla J, Khemani RG, et al. Thoracic duct ligation for persistent chylothorax after pediatric cardiothoracic surgery. Ann Thorac Surg. 2009;88:246–251discussion 251-2
  412. Warnes CA, Williams RG, Bashore TM, et al. ACC/AHA 2008 guidelines for the management of adults with congenital heart disease: executive summary. Circulation. 2008;118:2395–2451
  413. Marelli AJ, Therrien J, Mackie AS, et al. Planning the specialized care of adult congenital heart disease patients: from numbers to guidelines; an epidemiological approach. Am Heart J. 2009;157:1–8
  414. Hillman ND, Mavroudis C, Backer CL. Adult congenital heart disease. In:  Mavroudis C,  Backer CL editor. Pediatric Cardiac Surgery. Philadelphia: Mosby; 2003;p. 818–847
  415. Vida VL, Berggren H, Brawn WJ, et al. Risk of surgery for congenital heart disease in the adult: a multicentered European study. Ann Thorac Surg. 2007;83:161–168
  416. Fyler DC. Report of the New England regional infant cardiac program. Pediatrics. 1980;65:377
  417. Webb GD, Smallhorn JF, Therrien J, et al. Congenital heart disease. In:  Libby P,  Bonow RO,  Mann DL, et al. editor. Braunwald's Heart Disease. Philadelphia: Saunders; 2008;p. 1561–1624
  418. Wernovsky G, Jonas RA. Transposition of the great arteries. In:  Chang AC,  Hanley FL,  Wernovsky G, et al. editor. Pediatric Cardiac Intensive Care. Philadelphia: Williams & Wilkins; 1998;p. 289–301
  419. Aziz KU, Paul MH, Idriss FS, et al. Clinical manifestations of dynamic left ventricular outflow tract stenosis in infants with d-transposition of the great arteries with intact ventricular septum. Am J Cardiol. 1979;44:290–297
  420. Mair DD, Ritter DG. Factors influencing intercirculatory mixing in patients with complete transposition of the great arteries. Am J Cardiol. 1972;30:653–658
  421. Mair DD, Ritter DG. Factors influencing systemic arterial oxygen saturation in complete transposition of the great arteries. Am J Cardiol. 1973;31:742–748
  422. Rehnström P, Gilljam T, Südow G, et al. Excellent survival and low complication rate in medium-term follow-up after arterial switch operation for complete transposition. Scand Cardiovasc J. 2003;37:104–106
  423. Williams WG, McCrindle BW, Ashburn DA, et al. Outcomes of 829 neonates with complete transposition of the great arteries 12-17 years after repair. Eur J Cardiothorac Surg. 2003;24:1–9discussion 9-10
  424. Norwood WI, Dobell AR, Freed MD, et al. Intermediate results of the arterial switch repair (A 20-institution study). J Thorac Cardiovasc Surg. 1988;96:854–863
  425. Kouchoukas N, Blackstone E, Doty D, et al. Complete transposition of the great arteries. In:  Kouchoukas N,  Blackstone E,  Doty D, et al. editor. Kirklin/Barratt Boyes Cardiac Surgery. Oxford: Churchill Livingstone; 2003;p. 1438–1507
  426. Foran JP, Sullivan ID, Elliott MJ, et al. Primary arterial switch operation for transposition of the great arteries with intact ventricular septum in infants older than 21 days. J Am Coll Cardiol. 1998;31:883–889
  427. Kang N, de Leval MR, Elliott M, et al. Extending the boundaries of the primary arterial switch operation in patients with transposition of the great arteries and intact ventricular septum. Circulation. 2004;110(suppl 1):II123–II127
  428. Kurth CD, Steven JM, Nicolson SC, et al. Kinetics of cerebral deoxygenation during deep hypothermic circulatory arrest in neonates. Anesthesiology. 1992;77:656–661
  429. Grosfeld JL. The plight of children. Ann Surg. 2007;246:343–350
  430. Lawn JE, Cousens S, Zupan J. 4 million neonatal deaths: when? where? why?. Lancet. 2005;365:891–900
  431. Zupan J. Perinatal mortality in developing countries. N Engl J Med. 2005;352:2047–2048
  432. Cox JL. Presidential address: changing boundaries. J Thorac Cardiovasc Surg. 2001;122:413–418

PII: S0011-3840(09)00181-6

doi: 10.1067/j.cpsurg.2009.12.003

Current Problems in Surgery
Volume 47, Issue 4 , Pages 261-376 , April 2010

Article Tools

* Image Usage & Resolution